Objectives
We evaluated the prognostic value of heart rate reserve (DHR) and left ventricular ejection fraction reserve (DLVEF) among patients with systolic dysfunction. 
... Background
Inadequate DHR (maximal stress HR -resting HR) and DLVEF (LVEF at stress -LVEF at rest) in response to stress are associated with adverse cardiac events. However, the significance of an abnormal DHR and DLVEF in patients with systolic dysfunction has not been described. 
Methods and results
We performed a retrospective analysis of patients with rest LVEF < 45% who underwent dipyridamole stress-rest gated Rb-82 PET myocardial perfusion imaging (PET-MPI) at the Cleveland Clinic between 2006 and 2009. Stress LVEF and volumes were calculated using commercially available software (4DM). A Cox proportional hazards model (CPH) was used to examine the association between DLVEF, DHR, and all-cause death (ACD). Among 461 patients (mean age 65.7 ± 11.3 years, 82% men) 167 experienced ACD (median follow-up 1045 days). Survival was reduced among patients with DHR < 0 (1090 vs. 1300 days, P = 0.04) and DLVEF < 0 (1002 vs. 1057 days, P = 0.03). In a CPH after adjusting for confounding variables, DHR < _ 0 and DLVEF < _ 0 were associated with reduced survival (hazard ratio 0.93, P < 0.01 and 0.84, P = 0.01, respectively) with an interaction between age and DHR (v 2 = 8.1, P < 0.01). Our model predicts that the magnitude of DHR is associated with improved survival among younger patients. For any given DLVEF the magnitude of DHR has a greater positive effect on survival among younger patients.
Introduction
Chronotropic response to stress is an important predictor of future adverse cardiac events. 1, 2 An inadequate heart rate reserve (DHR), in response to exercise or vasodilator stress has been shown to be a prognostic marker of adverse cardiac events. 1, [3] [4] [5] [6] Similarly, a reduced left ventricular ejection fraction (LVEF) reserve (DLVEF), with vasodilator stress has been shown to be associated with significant risk of future adverse cardiac events with both single photon emission computed tomography (SPECT) and positron emission tomographymyocardial perfusion imaging (PET-MPI) studies. [7] [8] [9] [10] The aforementioned studies have included mostly patients with normal resting LVEF. However, the incremental prognostic value of an abnormal DLVEF in response to vasodilator stress among patients with an already reduced resting LVEF has not been examined. We hypothesized that DLVEF and DHR may provide additional prognostic information even among patients with resting LV systolic dysfunction. We sought to examine the independent prognostic value of DHR and DLVEF in response to pharmacologic stress in a high-risk group of patients with reduced resting LVEF.
Methods

Study population
This study was performed with approval from the Institutional 
Positron emission tomography and MPI
Patients were instructed to not consume caffeine for at least 24 h prior and fast for at least 6 h prior to the stress test. Beta blockers (BB), calcium channel blockers, and nitrates were withheld for 12 h prior to the test. Pharmacological stress was performed using dipyridamole (142 lg/kg/ min for 4 min). Resting HR and maximal HR with vasodilator stress were recorded (GE case v6.61, Milwaukee, WI, USA) along with systolic blood pressure (SBP) and diastolic blood pressure (DBP) (Philips Intellivue MP5, Bothell, WA, USA). Emission images were obtained for 5 min beginning 90-120 s after intravenous injection of 40-60 mCi of Rb-82 at rest and stress. DHR was given by maximal HR at stress-resting HR. DHR < _ 0 was defined as abnormal. ECG-gated rest and vasodilator stress PET-MPI was performed using a standard protocol according to the American Society of Nuclear Cardiology. 11 Attenuation correction was used for all studies.
Images were reconstructed as static and gated images for perfusion imaging and image analysis was performed using an automated program (Corridor4DM; Invia, Ann Arbor, MI, USA). Polar maps were derived and displayed using a standardized 17-segment model.
12
FDG-PET viability imaging
Positron emission tomography viability images were acquired on a Biograph mCT or Biograph Truepoint PET/CT (Siemens Molecular Imaging, Hoffman Estates, IL, USA). Patients were injected in the fasting state with 300 MBq (8 mCi) if blood glucose measured >100 mg/dL. Dextrose was administered 40 min prior to Fluorodeoxyglucose (FDG) injection if blood glucose was <100 mg/dL. Insulin was administered post-FDG injection to optimize myocardial glucose uptake; the dose was determined by a sliding scale based on post-injection blood glucose levels. One hour post-FDG injection, a computed tomography (CT) scan (120 kVp, 12 mAs) was performed after which PET images were acquired for 8 min at a single bed position. PET images were reconstructed using the iterative Ordered subset expectation-maximization algorithm with time of flight information (Biograph mCT only) and with point spread function modelling, using 128Â128 matrix, 4 mm Voxel size, 4 iterations, 21
subsets, and 8 mm Gaussian post-filter. Images were analysed with commercially available software after scatter and attenuation correction. Viable, hibernating myocardium comprised of regions that exhibited a lack of Rb-82 uptake at rest and stress but with preserved FDG uptake.
Regions with rest and stress perfusion abnormality and devoid of FDG uptake were identified as scar.
Image analysis
A 17-segment, 5-point scoring system was used for semi-quantitative assessment of perfusion and LV wall thickening. 6, 12 Summed stress score (SSS), summed rest score (SRS) and a summed difference score (SDS; SSS -SRS) were quantified. The percent of myocardium affected with a perfusion abnormality at stress or rest was given by the product of 100 and SSS/68 or SRS/68; the maximal score achievable for all 17 segments was 68. Abnormal PET-MPI was defined as an SSS > 0. LVEF as well as resting LV end-diastolic volume (LVEDV) and end-systolic volume (LVESV) were quantified from gated images. LVEF reserve (DLVEF) was given by the difference between LVEF with vasodilator stress and LVEF at rest. DLVEF < _0 was considered abnormal.
Follow-up and outcomes
All-cause death (ACD), the primary endpoint, was defined as death from any cause substantiated by the Social Security Death Index. The data were censored on 25 February 2011.
Statistical analysis
Continuous variables were reported as mean ± SD and were compared using Wilcoxon rank sum test. Categorical variables were reported as a proportion and compared using a v 2 test. A P < 0.05 was considered statistically significant. Statistical analysis was performed with S-PLUS 2000, TIBCO Software Inc., Palo Alto, CA, USA. The association between event-free survival, DHR, PET-MPI-based assessment of LVEF and DLVEF was evaluated using a Cox proportional hazards model. Factors that were considered relevant in influencing the risk for ACD based on previous publications or clinical knowledge were included in the model of ACD. The baseline model included medical history, medications, haemodynamic parameters, PET imaging-based measurements, and interventions. Incremental prognostic value was defined as a significant increase in the Wald statistic after the addition of PET-imaging data to other baseline clinical information. Interaction between variables was examined and included in the model based on a partial likelihood ratio test. Overfitting was avoided by limiting the number of variables used in the model. The model was evaluated for linearity, proportional hazards, multicollinearity, and the additive value of the terms.
Results
Patient characteristics
Demographics and medical history Overall, patients were 65.7 ± 11.3 year-old with 101 (21.9%) women and BMI was 28.9 ± 6.4 ( Table 1 ). Greater than 50% of patients had myocardial infarction and had undergone coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). Moderate or severe aortic stenosis (AS) was present in 32 (7%) patients and 96 (21%) had moderate or severe mitral regurgitation ( Table 1) . 
Outcomes
In all, 167 events-ACD-occurred over a median follow-up of 1045.5 days; annualized event rate of 34.8/year. Patients with ACD were older, (68.9 ± 10.5 vs. 63.9 ± 11.4) with lower BMI (27.8 ± 6.6 vs. 29.6 ± 6.3 kg/m 2 ), compared with patients free of events. A greater proportion of patients in the group with ACD had diabetes and were treated with angiotensin converting enzyme inhibitors (ACEI) compared with the event-free group ( Table 2) . History of CABG or PCI was similar between the two groups; however, a greater proportion of patients in the event-free group had an implantable cardiac defibrillator (ICD) in place prior to MPI and had undergone CABG after MPI compared with those who experienced events. Valvular heart disease (MR or more than mild AS) was present disproportionately among patients who had events ( Table 2) .
MPI findings
In the overall cohort, 456 (98%) patients had an abnormal PET-MPI and 423 (89%) had inducible ischaemia. The proportion of individuals with abnormal MPI and, percent of ischaemic myocardium was similar in patients with ACD and those free of events ( Table 2 ). The percent of hibernating myocardium and myocardium affected by scar was similar between patients with ACD and patients free of ACD ( Table 2) . Patients with ACD had lower LVEF and larger resting left ventricular end-diastolic volume index (LVEDVI) and end-systolic volume index (LVESVI) ( Table 2 ). In the overall cohort, there were 199 (41.9%) patients with abnormal DLVEF. A greater proportion of patients who experienced ACD had abnormal DLVEF, 83 (50%) compared with patients free of ACD, 116 (39%; P = 0.03).
Haemodynamic measurements
Both resting and peak stress SBP and DBP were lower and, there was a greater decrease in SBP and a greater increase in DBP in response to vasodilator stress among patients with ACD relative to those free of events. Resting HR was also higher among those with ACD. Peak HR in response to vasodilator stress was similar in both groups; however, DHR was significantly lower in the group that experienced ACD compared with patients free of events.
Survival was significantly reduced in patients with abnormal DLVEF compared to those with a normal DLVEF (P = 0.028). Median survival time was 1057 days (95% CI 1015-1099) in those with normal DLVEF compared with 1002 days (95% CI 918-1086) among patients with abnormal DLVEF. Similarly, patients with a normal DHR had an improved survival (median survival 1090 days, 95% CI 1232-1369) compared with patients with abnormal DHR (median survival 1300 days, 95% CI 1210-1338; P = 0.041).
Multivariable Cox proportional hazards modelling
In the multivariable Cox-proportional hazards model, age, diabetes, BB use, percent of hibernating myocardium, ICD implantation following stress-MPI, resting HR, DHR, LVEF, and DLVEF were predictors of ACD (v 2 = 97.6, P < 0.0001). Resting LVEF, normal DLVEF, and ICD implantation post-stress testing were predictors of favourable outcomes with a hazard ratio <1 for ACD. In contrast, diabetes and percent of hibernating myocardium were associated with an increased risk for events ( Table 3) .
There was a significant interaction between BB use and resting HR in our model (v 2 = 4.82, P = 0.03). In the presence of BB, resting HR does not impact ACD; however, in the absence of BB, the hazard ratio for ACD increases with increase in resting HR ( Figure 1A) . There was also an interaction between age and DHR in response to vasodilator stress (v 2 = 8.1, P < 0.01). Based on our model, the prognostic effect of DHR is modified by the patient's age. In the absence of BB, DHR has a greater impact on survival among younger patients compared with those who are older ( Figure 1B) . In a young patient, a high resting HR is associated with increased risk of ACD; however, this effect may be ameliorated if the patient exhibits a robust DHR in response to stress (Figure 2A) . In patients who are slightly older, our model predicts that a robust increase in DHR in response to stress continues to offset the negative effect of a high resting HR on survival; however, the effect is blunted compared with young patients ( Figure 2B ). In contrast, among significantly older patients, the impact of a high resting HR on ACD is almost independent of DHR and high resting HR increases the hazard for ACD despite a robust DHR ( Figure 2C ). After adjusting for patient age, the effect of DHR on ACD is similar across a range of DLVEF from -5 to 20% (Figure 3) , with risk of ACD increasing with reductions in DHR. For any given DLVEF, in a young patient, our model predicts a steep drop in hazard for ACD when there is an increase in DHR ( Figure 4A ). In contrast, in significantly older patients for any given level of DLVEF, there is a limited impact of changes in DHR on the hazard for ACD ( Figure 4B ).
Discussion
In this study of patients with systolic dysfunction undergoing vasodilator stress PET-MPI, we show for the first time that resting HR, DHR, and DLVEF are prognostically important in predicting ACD after accounting for clinical risk factors including age, BB, resting LVEF, and percent of jeopardized myocardium. We have made the following observations. A reduced DLVEF in response to vasodilator stress is predictive of ACD; in the absence of BB, a high resting HR is associated with poor outcomes, and the impact of DHR on ACD is modified by age. Exercise stress is associated with an increase in HR as well as an increase in contractility to augment cardiac output. [13] [14] [15] This normal response to exercise may be blunted in patients with cardiovascular disease including CAD and cardiomyopathy. 9, 13, 16 Studies have shown that individuals who exhibit a blunted DHR in response to exercise may experience an increase in adverse cardiac events. 1,2,17 An abnormal DHR has therefore been considered a surrogate marker of underlying cardiovascular abnormalities and risk of adverse events. In SPECT-MPI studies, an inadequate DHR in response to exercise or vasodilator stress, has been shown to provide incremental value for predicting adverse cardiac outcomes; 6, 18 however, most of the patients included in these studies had a normal resting LVEF. 6, 18 Similarly, blunted DHR during vasodilator stress, whether as an adjunct to PET-MPI or echocardiography has also shown to add incremental value after adjusting for other factors. 4, 5 Patients with reduced LVEF may exhibit a blunted DHR in response to exercise stress. 19, 20 However, the incremental prognostic value of an inappropriate chronotropic response to vasodilator stress has not been examined in this patient population. 21, 22 Our observations are consistent with previous studies that demonstrate that DHR may be an important parameter with prognostic significance.
1,2,17 Overall, there was no difference in DHR (10.52 vs.
9.08, P = 0.145) or DLVEF (1.78 vs. 3.10, P = 0.09) between the groups that received beta blockers and the group without beta blockers. After adjusting for age and BB use, an abnormal DHR in response to vasodilator stress is a predictor of poor outcomes. Further, analysis of our model revealed an interaction between DHR and age such that for any given DHR, older patients have a less profound improvement in outcomes compared with younger patients. To our knowledge, this is the first time that an interaction of DHR and age in association with ACD has been shown in a group of patients undergoing pharmacologic stress. Resting HR has been shown to be an independent prognostic factor for all-cause mortality. [23] [24] [25] [26] However, it is not known if resting HR would still emerge as a prognostic indicator of outcomes in a group of patients who may already be at a high risk for adverse events by virtue of their low LVEF. Our model demonstrated that resting HR has a strong impact on predicting ACD. We observed that the relative prognostic value of resting HR and DHR was strongly affected by age. Our model predicts that young patients with a high resting HR may derive a greater benefit when they exhibit a high DHR in response to stress compared with older patients. On the other hand, with advanced age, resting HR may become a more important determinant of survival compared with DHR. Previous studies have shown that resting HR is of prognostic importance in elderly patients. 27, 28 However, the increased prognostic value of resting HR relative to DHR in older patients with a reduced LVEF is a novel finding. Our study also highlights the prognostic value of DLVEF with respect to outcomes. Previous studies have shown that post-stress LVEF and ESV by gated-SPECT are prognostically significant over pre-scan and perfusion information in predicting cardiac death. 9 DLVEF has also been shown to be related to the extent of perfusion abnormalities detected by PET-MPI. 29 Resting LVEF is an independent prognostic factor for ACD and individuals with LVEF < 45% have been found to have a greater mortality than those with a normal LVEF. 3, 10, [30] [31] [32] A significant number of patients referred for PET-MPI for perfusion imaging have a higher disease burden and a low LVEF. 33, 34 We therefore focused on a group of patients with a reduced LVEF to determine if DLVEF would still offer similar prognostic information. We observe that after including resting LVEF, LV size, percent of jeopardized myocardium, and haemodynamic parameters, a normal DLVEF is associated with improved survival. Based on our model, a low DLVEF combined with an attenuated DHR is associated with reduced survival. Even if the DLVEF was normal, a low DHR predicts poor outcomes. Once again, the relative effects of DLVEF and DHR are age-dependent. In a young patient, a modest increase in DHR may offset the negative effect of a poor DLVEF on survival. However, with advancing age, even a significant increase in DHR has a modest and limited effect on survival and may be a predictor of poor outcomes when DLVEF is low. To our knowledge, this is the first study to illustrate the complex relationship between DLVEF, DHR, and age in how they may predict ACD. This is also the first study to examine the incremental prognostic value of these parameters in a population with an already increased baseline risk for adverse cardiac events as a result of a low resting LVEF.
Limitations
This was a retrospective single-centre study of patients with relatively complex cardiovascular disease and therefore suffers from referral and selection bias which limits the generalizability of the findings. The study is limited with respect to follow-up especially with respect to cardiac events vs. non-cardiac events. Our study population is further restricted by the selection of patients with low LVEF. We chose to examine ACD since information regarding cardiac death was not known for all individuals. All studies were performed with dipyridamole as the pharmacologic stress agent and it is likely that results may not be generalizable to vasodilators with a shorter half-life such as adenosine or regadenoson. Since the goal of the study was to examine the incremental value of DLVEF and DHR and not to examine the independent effects of interventions such as CABG or ICD implantation, these variables were included in the model as non-time dependent covariates. Vasodilator stress is known to cause an increase in contractile response which correlates directly with endocardial flow reserve; however, studies that have examined the effect of vasodilator stress on DLVEF have not specifically addressed the contribution of vasodilator induced changes in contractility vs. DHR in response to stress. [7] [8] [9] [10] One might extrapolate that changes in DLVEF represent alterations in contractility in response to vasodilators. Similarly, our report focused on the relative importance of DHR, resting HR and DLVEF for prognostication. In this case, DLVEF may be considered to represent changes in myocardial contractility in response to vasodilator stress. Figure 2 Differential effect of resting HR, and DHR on survival based on age. The predicted impact of DHR on the relationship between resting HR and survival is shown among young patients (A), middle-aged patients (B) and older patients (C). In young and middle-aged patients, a robust DHR offsets the reduced survival due to high resting HR. Whereas, in older individuals the protective effect of DHR on survival is blunted in the face of high resting HR. 
Conclusion
Among patients with reduced LVEF who underwent vasodilator stress myocardial perfusion PET, resting HR, DHR and DLVEF were prognostically important in predicting ACD after accounting for clinically important risk factors. The relative importance of resting HR, DHR, and DLVEF in affecting ACD were dependent upon age. A significant DHR was relatively more important than DLVEF for improved survival among young patients; however, in older patients, a reduced DLVEF was associated with reduced survival despite an appropriate DHR.
